CJC-1295 & Ipamorelin
CJC-1295 and Ipamorelin Synergy Research
Research suggests combined activation of the GHRH receptor (CJC-1295) and the GHS-R1a receptor (ipamorelin) produces a larger pulsatile growth-hormone release than either peptide alone. This is consistent with the well-characterised complementary physiology of GHRH and ghrelin signalling on somatotrophs.
Key facts
- Rationale
- Complementary pathways to GH release
- Effect
- Larger combined GH pulse in reported studies
Physiological basis
GHRH and ghrelin normally work together in vivo to generate GH pulses. Combined pharmacological activation replicates this dual input in a research setting.
Extended research context
The CJC-1295 & Ipamorelin deep dive
Deep dive: why CJC-1295 and Ipamorelin are studied together
CJC-1295 is a modified GHRH (growth-hormone-releasing hormone) analogue; Ipamorelin is a selective growth-hormone secretagogue that binds the ghrelin receptor (GHS-R1a). In pituitary-cell research models the two act on independent pathways whose downstream effect converges on GH release — CJC-1295 amplifies the endogenous GHRH signal while Ipamorelin adds a separate ghrelin-pathway stimulus. That's why supplier catalogues frequently package them together as a research reference blend.
DAC vs no-DAC: which CJC-1295 is which
'CJC-1295 with DAC' contains a Drug Affinity Complex (a Lys-maleimide moiety) that binds serum albumin and extends half-life to several days. 'CJC-1295 no-DAC' (also called Modified GRF 1-29) lacks the linker and clears in minutes. These are pharmacologically different peptides. A CoA must specify which form is in the vial; mass differs (~3,367 Da with DAC vs ~3,367 minus linker for no-DAC).
Ipamorelin's selectivity profile
Unlike earlier GHS-R agonists (e.g. GHRP-6), Ipamorelin was engineered for minimal cross-activity at cortisol- and prolactin-releasing pathways in research models. That receptor selectivity is why it is the reference secretagogue for controlled pituitary-cell studies.
Research applications
- ▸Pituitary-cell GH-release assays (comparator vs GHRH and hexarelin)
- ▸Half-life comparison studies: DAC vs no-DAC CJC-1295 forms
- ▸Ghrelin-receptor binding assays for Ipamorelin analogue development
- ▸Analytical HPLC method development for lipidated GHRH analogues
- ▸Stability testing under refrigerated storage
Handling checklist
- ✓Store lyophilised at −20 °C long-term
- ✓Reconstitute in bacteriostatic water; both peptides dissolve readily
- ✓Aliquot immediately, refrigerate at 2–8 °C, use within 28 days
- ✓Confirm salt form and DAC/no-DAC status on CoA before starting a study
- ✓Do not use for human administration — research reference only
Common research-handling mistakes
Learnt from thousands of researcher orders across our UK labs.
✗ Confusing DAC and no-DAC CJC-1295
Fix: Check the CoA — the two have very different pharmacokinetics.
✗ Assuming Ipamorelin acts on GHRH receptors
Fix: It binds the ghrelin receptor (GHS-R1a) — a separate pathway from CJC-1295.
✗ Storing reconstituted solution at room temperature
Fix: Refrigerate 2–8 °C after reconstitution.
Continue researching
Peer-reviewed guides, comparators and matched reference materials.
Related questions researchers ask
- Is CJC-1295 the same as Modified GRF 1-29?
- What is the difference between DAC and no-DAC CJC-1295?
- Does Ipamorelin raise cortisol?
- Why are CJC-1295 and Ipamorelin blended together?
- How long is the half-life of CJC-1295 with DAC?
Frequently asked questions
- Is the combination approved?
- No — neither peptide is approved, and the combination is a research paradigm only.
Primary sources & clinical trials
Peer-reviewed research and registered trials from PubMed, ClinicalTrials.gov, PubChem, FDA and NIH. All links open in a new tab and point to the primary source, so every claim can be verified at origin.
- PubMedPubMed — GHRH ghrelin synergypubmed.ncbi.nlm.nih.gov
- PubMedTeichman et al., Prolonged stimulation of GH & IGF-I by CJC-1295 — J Clin Endocrinol Metab 2006 (PMID 16352683)pubmed.ncbi.nlm.nih.gov
- PubMedRaun et al., Ipamorelin, the first selective GH secretagogue — Eur J Endocrinol 1998 (PMID 9849822)pubmed.ncbi.nlm.nih.gov
- PubMedSinha et al., Growth-hormone secretagogues — Endocr Rev (PMID 15855273)pubmed.ncbi.nlm.nih.gov
- PubChemPubChem · CJC-1295 (CID 16137828)pubchem.ncbi.nlm.nih.gov
- PubChemPubChem · Ipamorelin (CID 9831659)pubchem.ncbi.nlm.nih.gov
- TrialClinicalTrials.gov · GH-secretagogue trialsclinicaltrials.gov
- GuidelineGoogle — Creating helpful, reliable, people-first contentdevelopers.google.com
Written and reviewed by
Jack Muncaster · Founder, UK Peptides
Jack founded UK Peptides in Manchester after repeatedly receiving research compounds with missing or recycled paperwork. He is responsible for supplier selection, batch release decisions and the content published in this research library. Every article here is sourced to primary literature and every product page to a signed third-party certificate.
More CJC-1295 & Ipamorelin articles
- Modified GRF 1-29 ExplainedModified GRF 1-29 is CJC-1295 without the DAC linker: a 30-residue GHRH analogue with a short (~30-minute) plasma half-life used in research.
- Ipamorelin Sequence and Chemical IdentityIpamorelin sequence: Aib-His-D-2-Nal-D-Phe-Lys-NH₂. Pentapeptide with molecular weight ~711 Da. Chemical identity, CAS, and structural notes.
- CJC-1295 CAS Number and IdentityCJC-1295 CAS: 863288-34-0 (no DAC / Mod GRF 1-29) and 863288-38-4 (with DAC). Chemical identifiers and identity verification.
- CJC-1295 Half-Life: DAC vs Non-DACCJC-1295 with DAC has a half-life of ~7 days via covalent albumin binding; without DAC (Mod GRF 1-29) it clears in ~30 minutes.
- The Walker 2006 CJC-1295 StudyTeichman et al. (JCEM 2006) reported CJC-1295 with DAC extends plasma GHRH activity in healthy adults with a ~1-week half-life. Landmark PK study summary.
Popular across the research hub
One flagship guide from every other research category — keep exploring.
- Retatrutide ResearchRetatrutide Clinical Trial Timeline: Phase 1 to TRIUMPH
- GHK-Cu (Copper Peptide)Why GHK-Cu Declines With Age (Research)
- TB-500 (Thymosin β4 fragment)TB-500 CAS Number and Chemical Identity
- BPC-157 (Pentadecapeptide)BPC-157 CAS Number and Chemical Identity
- Peptide ReferenceWhat Are Peptides? Complete Guide
- Bacteriostatic WaterBacteriostatic Water for Reconstitution Explained